Sample Request

2020-2025 Global RNA-interference (RNAi) Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)

SELECT LICENSE:

Published on 03/02/2021| Code: MAR41115D| Category: Utilities| Total Pages: 96

RNA interference is a biological process in which RNA molecules inhibit gene expression or translation, by neutralizing targeted mRNA molecules. Historically, RNAi was known by other names, including co-suppression, post-transcriptional gene silencing, and quelling.

This report elaborates the market size, market characteristics, and market growth of the RNA-interference (RNAi) industry, and breaks down according to the type, application, and consumption area of RNA-interference (RNAi). The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for RNA-interference (RNAi) in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.

In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global RNA-interference (RNAi) market covered in Chapter 13:

Merck & Co. Inc. (Sigma Aldrich)
Dicerna Pharmaceuticals
RXI Pharmaceuticals
Quark Pharmaceuticals Inc.
Arrowhead
Ionis Pharmaceuticals Inc.
Qiagen NV
Arcturus Therapeutics
Phio Pharmaceuticals Corp.
Tekmira Pharmaceuticals Corporation
ISIS Pharmaceuticals
Silence Therapeutics PLC
Benitec Biopharma Ltd
Thermo Fisher Scientific Inc.
Alnylam Pharmaceuticals

In Chapter 6, on the basis of types, the RNA-interference (RNAi) market from 2015 to 2025 is primarily split into:

Chemical synthesis
In vitro transcription
In vivo expression

In Chapter 7, on the basis of applications, the RNA-interference (RNAi) market from 2015 to 2025 covers:

Drug Discovery and Development
Therapeutics

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:

United States

Europe

China

Japan

India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:

North America (Covered in Chapter 8)

United States

Canada

Mexico

Europe (Covered in Chapter 9)

Germany

UK

France

Italy

Spain

Others

Asia-Pacific (Covered in Chapter 10)

China

Japan

India

South Korea

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 11)

Saudi Arabia

UAE

South Africa

Others

South America (Covered in Chapter 12)

Brazil

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

Table of Content

1 RNA-interference (RNAi) Market - Research Scope

1.1 Study Goals

1.2 Market Definition and Scope

1.3 Key Market Segments

1.4 Study and Forecasting Years

2 RNA-interference (RNAi) Market - Research Methodology

2.1 Methodology

2.2 Research Data Source

2.2.1 Secondary Data

2.2.2 Primary Data

2.2.3 Market Size Estimation

2.2.4 Legal Disclaimer

3 RNA-interference (RNAi) Market Forces

3.1 Global RNA-interference (RNAi) Market Size

3.2 Top Impacting Factors (PESTEL Analysis)

3.2.1 Political Factors

3.2.2 Economic Factors

3.2.3 Social Factors

3.2.4 Technological Factors

3.2.5 Environmental Factors

3.2.6 Legal Factors

3.3 Industry Trend Analysis

3.4 Industry Trends Under COVID-19

3.4.1 Risk Assessment on COVID-19

3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry

3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario

3.5 Industry Risk Assessment

4 RNA-interference (RNAi) Market - By Geography

4.1 Global RNA-interference (RNAi) Market Value and Market Share by Regions

4.1.1 Global RNA-interference (RNAi) Value ($) by Region (2015-2020)

4.1.2 Global RNA-interference (RNAi) Value Market Share by Regions (2015-2020)

4.2 Global RNA-interference (RNAi) Market Production and Market Share by Major Countries

4.2.1 Global RNA-interference (RNAi) Production by Major Countries (2015-2020)

4.2.2 Global RNA-interference (RNAi) Production Market Share by Major Countries (2015-2020)

4.3 Global RNA-interference (RNAi) Market Consumption and Market Share by Regions

4.3.1 Global RNA-interference (RNAi) Consumption by Regions (2015-2020)

4.3.2 Global RNA-interference (RNAi) Consumption Market Share by Regions (2015-2020)

5 RNA-interference (RNAi) Market - By Trade Statistics

5.1 Global RNA-interference (RNAi) Export and Import

5.2 United States RNA-interference (RNAi) Export and Import (2015-2020)

5.3 Europe RNA-interference (RNAi) Export and Import (2015-2020)

5.4 China RNA-interference (RNAi) Export and Import (2015-2020)

5.5 Japan RNA-interference (RNAi) Export and Import (2015-2020)

5.6 India RNA-interference (RNAi) Export and Import (2015-2020)

5.7 ...

6 RNA-interference (RNAi) Market - By Type

6.1 Global RNA-interference (RNAi) Production and Market Share by Types (2015-2020)

6.1.1 Global RNA-interference (RNAi) Production by Types (2015-2020)

6.1.2 Global RNA-interference (RNAi) Production Market Share by Types (2015-2020)

6.2 Global RNA-interference (RNAi) Value and Market Share by Types (2015-2020)

6.2.1 Global RNA-interference (RNAi) Value by Types (2015-2020)

6.2.2 Global RNA-interference (RNAi) Value Market Share by Types (2015-2020)

6.3 Global RNA-interference (RNAi) Production, Price and Growth Rate of Chemical synthesis (2015-2020)
6.4 Global RNA-interference (RNAi) Production, Price and Growth Rate of In vitro transcription (2015-2020)
6.5 Global RNA-interference (RNAi) Production, Price and Growth Rate of In vivo expression (2015-2020)

7 RNA-interference (RNAi) Market - By Application

7.1 Global RNA-interference (RNAi) Consumption and Market Share by Applications (2015-2020)

7.1.1 Global RNA-interference (RNAi) Consumption by Applications (2015-2020)

7.1.2 Global RNA-interference (RNAi) Consumption Market Share by Applications (2015-2020)

7.2 Global RNA-interference (RNAi) Consumption and Growth Rate of Drug Discovery and Development (2015-2020)
7.3 Global RNA-interference (RNAi) Consumption and Growth Rate of Therapeutics (2015-2020)

8 North America RNA-interference (RNAi) Market

8.1 North America RNA-interference (RNAi) Market Size

8.2 United States RNA-interference (RNAi) Market Size

8.3 Canada RNA-interference (RNAi) Market Size

8.4 Mexico RNA-interference (RNAi) Market Size

8.5 The Influence of COVID-19 on North America Market

9 Europe RNA-interference (RNAi) Market Analysis

9.1 Europe RNA-interference (RNAi) Market Size

9.2 Germany RNA-interference (RNAi) Market Size

9.3 United Kingdom RNA-interference (RNAi) Market Size

9.4 France RNA-interference (RNAi) Market Size

9.5 Italy RNA-interference (RNAi) Market Size

9.6 Spain RNA-interference (RNAi) Market Size

9.7 The Influence of COVID-19 on Europe Market

10 Asia-Pacific RNA-interference (RNAi) Market Analysis

10.1 Asia-Pacific RNA-interference (RNAi) Market Size

10.2 China RNA-interference (RNAi) Market Size

10.3 Japan RNA-interference (RNAi) Market Size

10.4 South Korea RNA-interference (RNAi) Market Size

10.5 Southeast Asia RNA-interference (RNAi) Market Size

10.6 India RNA-interference (RNAi) Market Size

10.7 The Influence of COVID-19 on Asia Pacific Market

11 Middle East and Africa RNA-interference (RNAi) Market Analysis

11.1 Middle East and Africa RNA-interference (RNAi) Market Size

11.2 Saudi Arabia RNA-interference (RNAi) Market Size

11.3 UAE RNA-interference (RNAi) Market Size

11.4 South Africa RNA-interference (RNAi) Market Size

11.5 The Influence of COVID-19 on Middle East and Africa Market

12 South America RNA-interference (RNAi) Market Analysis

12.1 South America RNA-interference (RNAi) Market Size

12.2 Brazil RNA-interference (RNAi) Market Size

12.3 The Influence of COVID-19 on South America Market

13 Company Profiles

13.1 Merck & Co. Inc. (Sigma Aldrich)
13.1.1 Merck & Co. Inc. (Sigma Aldrich) Basic Information
13.1.2 Merck & Co. Inc. (Sigma Aldrich) Product Profiles, Application and Specification
13.1.3 Merck & Co. Inc. (Sigma Aldrich) RNA-interference (RNAi) Market Performance (2015-2020)
13.2 Dicerna Pharmaceuticals
13.2.1 Dicerna Pharmaceuticals Basic Information
13.2.2 Dicerna Pharmaceuticals Product Profiles, Application and Specification
13.2.3 Dicerna Pharmaceuticals RNA-interference (RNAi) Market Performance (2015-2020)
13.3 RXI Pharmaceuticals
13.3.1 RXI Pharmaceuticals Basic Information
13.3.2 RXI Pharmaceuticals Product Profiles, Application and Specification
13.3.3 RXI Pharmaceuticals RNA-interference (RNAi) Market Performance (2015-2020)
13.4 Quark Pharmaceuticals Inc.
13.4.1 Quark Pharmaceuticals Inc. Basic Information
13.4.2 Quark Pharmaceuticals Inc. Product Profiles, Application and Specification
13.4.3 Quark Pharmaceuticals Inc. RNA-interference (RNAi) Market Performance (2015-2020)
13.5 Arrowhead
13.5.1 Arrowhead Basic Information
13.5.2 Arrowhead Product Profiles, Application and Specification
13.5.3 Arrowhead RNA-interference (RNAi) Market Performance (2015-2020)
13.6 Ionis Pharmaceuticals Inc.
13.6.1 Ionis Pharmaceuticals Inc. Basic Information
13.6.2 Ionis Pharmaceuticals Inc. Product Profiles, Application and Specification
13.6.3 Ionis Pharmaceuticals Inc. RNA-interference (RNAi) Market Performance (2015-2020)
13.7 Qiagen NV
13.7.1 Qiagen NV Basic Information
13.7.2 Qiagen NV Product Profiles, Application and Specification
13.7.3 Qiagen NV RNA-interference (RNAi) Market Performance (2015-2020)
13.8 Arcturus Therapeutics
13.8.1 Arcturus Therapeutics Basic Information
13.8.2 Arcturus Therapeutics Product Profiles, Application and Specification
13.8.3 Arcturus Therapeutics RNA-interference (RNAi) Market Performance (2015-2020)
13.9 Phio Pharmaceuticals Corp.
13.9.1 Phio Pharmaceuticals Corp. Basic Information
13.9.2 Phio Pharmaceuticals Corp. Product Profiles, Application and Specification
13.9.3 Phio Pharmaceuticals Corp. RNA-interference (RNAi) Market Performance (2015-2020)
13.10 Tekmira Pharmaceuticals Corporation
13.10.1 Tekmira Pharmaceuticals Corporation Basic Information
13.10.2 Tekmira Pharmaceuticals Corporation Product Profiles, Application and Specification
13.10.3 Tekmira Pharmaceuticals Corporation RNA-interference (RNAi) Market Performance (2015-2020)
13.11 ISIS Pharmaceuticals
13.11.1 ISIS Pharmaceuticals Basic Information
13.11.2 ISIS Pharmaceuticals Product Profiles, Application and Specification
13.11.3 ISIS Pharmaceuticals RNA-interference (RNAi) Market Performance (2015-2020)
13.12 Silence Therapeutics PLC
13.12.1 Silence Therapeutics PLC Basic Information
13.12.2 Silence Therapeutics PLC Product Profiles, Application and Specification
13.12.3 Silence Therapeutics PLC RNA-interference (RNAi) Market Performance (2015-2020)
13.13 Benitec Biopharma Ltd
13.13.1 Benitec Biopharma Ltd Basic Information
13.13.2 Benitec Biopharma Ltd Product Profiles, Application and Specification
13.13.3 Benitec Biopharma Ltd RNA-interference (RNAi) Market Performance (2015-2020)
13.14 Thermo Fisher Scientific Inc.
13.14.1 Thermo Fisher Scientific Inc. Basic Information
13.14.2 Thermo Fisher Scientific Inc. Product Profiles, Application and Specification
13.14.3 Thermo Fisher Scientific Inc. RNA-interference (RNAi) Market Performance (2015-2020)
13.15 Alnylam Pharmaceuticals
13.15.1 Alnylam Pharmaceuticals Basic Information
13.15.2 Alnylam Pharmaceuticals Product Profiles, Application and Specification
13.15.3 Alnylam Pharmaceuticals RNA-interference (RNAi) Market Performance (2015-2020)

14 Market Forecast - By Regions

14.1 North America RNA-interference (RNAi) Market Forecast (2020-2025)

14.2 Europe RNA-interference (RNAi) Market Forecast (2020-2025)

14.3 Asia-Pacific RNA-interference (RNAi) Market Forecast (2020-2025)

14.4 Middle East and Africa RNA-interference (RNAi) Market Forecast (2020-2025)

14.5 South America RNA-interference (RNAi) Market Forecast (2020-2025)

15 Market Forecast - By Type and Applications

15.1 Global RNA-interference (RNAi) Market Forecast by Types (2020-2025)

15.1.1 Global RNA-interference (RNAi) Market Forecast Production and Market Share by Types (2020-2025)

15.1.2 Global RNA-interference (RNAi) Market Forecast Value and Market Share by Types (2020-2025)

15.2 Global RNA-interference (RNAi) Market Forecast by Applications (2020-2025)

Our Clients

BIC
Suntory Holdings
Continental AG
Ernst Klett
felix
IF Logo
ITC logo
jc
KB
KKR
LR
LSC
Prospect
SRG
Sumitomo
Taichin logo
The Cleanest Way
Meat & Livestock Australia Limited
LEK
IFFCO
STTS
Laundry Capital LLC
Chippenhook Corporation
SAB
IJIN
Hooton
Medica
Medalliacne
Shanghai Chenzhu Instrument Co., Ltd.
Sanofi
Kleen Linnebo und Partner GbR
Bond-Pro, Inc.
E&L Faster Food Imports Inc.
Okinawa Institute of Science and Technology
Mizuno Corp

Need Help?

Please fill form below:

Contact Us

99 WALL STREET #2124 NEW YORK, NY 10005